Vitamin D supplementation shows no significant effect on acute respiratory infections overall, but children and daily low doses may offer protective benefits.
Teva, Royalty Pharma to expedite olanzapine LAI programme
Share this article Olanzapine LAI is being analysed in a Phase III trial to treat schizophrenia. Credit: Doidam 10 / Shutterstock.com Teva Pharmaceuticals has entered a